The main issue regarding TRIP12 gene alterations and in particular point mutations is whether these mutations play a causal role in cancer initiation or progression (“driver” mutations) or if they only randomly appear during cancer establishment as a consequence of, for instance, DNA repair failure (“passenger” mutations). The gene discussed is TRIP12; the disease is cancer.